235275

Ondansetron injection is an antiemetic drug in liquid form. It is a 5-HT3 receptor antagonist used to prevent nausea and vomiting associated with chemotherapy and radiotherapy, and in the prevention and treatment of postoperative nausea and vomiting. It is available in a multiple-dose 20-millilitre vial, and in single dose vials of two and four millilitres.

This product meets the terms of heading 30.04 of the Harmonized System. Specifically, it is a drug for therapeutic use imported in a form or packing for retail sale.

In accordance with General Interpretative Rule 1 of the Harmonized System, the ondansetron injection is classified under classification number 3004.90.00.49 of the Customs Tariff.